Literature DB >> 20811045

The role of RPE cell-associated VEGF₁₈₉ in choroidal endothelial cell transmigration across the RPE.

Haibo Wang1, Pete Geisen, Erika S Wittchen, Bradley King, Keith Burridge, Patricia A D'Amore, M Elizabeth Hartnett.   

Abstract

PURPOSE: To determine the role of vascular endothelial growth factor 189 (VEGF₁₈₉) in choroidal endothelial cell (CEC) migration across the retinal pigment epithelium (RPE) and to explore the molecular mechanisms involved.
METHODS: Using real-time PCR, the expression of VEGF splice variants VEGF₁₂₁, VEGF₁₆₅, and VEGF₁₈₉ was determined in human RPE from donor eyes, cultured human RPE in contact with CECs exposed to hydrogen peroxide (H₂O₂) or hypoxia, and RPE/choroid specimens from mice treated with laser to induce choroidal neovascularization (CNV). Activation of VEGF receptors (VEGFRs), phosphoinositol 3-kinase (PI-3K) or Rac1 was measured in CECs cocultured in contact with RPE exposed to peroxide or silenced for VEGF₁₈₉ expression. Migration of CECs across the RPE was determined using fluorescence microscopy.
RESULTS: VEGF₁₈₉ expression was increased in human RPE from aged compared with young donor eyes and from mouse RPE/choroids after laser to induce CNV. VEGF₁₈₉ was also upregulated in human RPE challenged with peroxide, hypoxia, or cultured in contact with CECs. CEC migration across RPE was greater after RPE exposure to peroxide to induce VEGF₁₈₉; VEGFR2 and Rac1 activities were also increased in these CECs. When CECs were cocultured with RPE silenced for VEGF₁₈₉, VEGFR2 and Rac1 activities in CECs were significantly reduced, as was CEC migration across the RPE. Inhibition of Rac1 activity significantly inhibited CEC transmigration without affecting PI-3K activity.
CONCLUSIONS: RPE-derived cell-associated VEGF₁₈₉ facilitates CEC transmigration by Rac1 activation independently of PI-3K signaling and may have importance in the development of neovascular AMD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20811045      PMCID: PMC3053298          DOI: 10.1167/iovs.10-5595

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  50 in total

1.  Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188.

Authors:  P Carmeliet; Y S Ng; D Nuyens; G Theilmeier; K Brusselmans; I Cornelissen; E Ehler; V V Kakkar; I Stalmans; V Mattot; J C Perriard; M Dewerchin; W Flameng; A Nagy; F Lupu; L Moons; D Collen; P A D'Amore; D T Shima
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

Review 2.  Mechanisms of angiogenesis.

Authors:  W Risau
Journal:  Nature       Date:  1997-04-17       Impact factor: 49.962

3.  Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro.

Authors:  W J Lamoreaux; M E Fitzgerald; A Reiner; K A Hasty; S T Charles
Journal:  Microvasc Res       Date:  1998-01       Impact factor: 3.514

4.  Expression of vascular endothelial growth factor in experimental choroidal neovascularization.

Authors:  T Ishibashi; Y Hata; H Yoshikawa; K Nakagawa; K Sueishi; H Inomata
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-03       Impact factor: 3.117

5.  Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1beta-mediated breakdown.

Authors:  J D Luna; C C Chan; N L Derevjanik; J Mahlow; C Chiu; B Peng; T Tobe; P A Campochiaro; S A Vinores
Journal:  J Neurosci Res       Date:  1997-08-01       Impact factor: 4.164

6.  Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo.

Authors:  M Kuroki; E E Voest; S Amano; L V Beerepoot; S Takashima; M Tolentino; R Y Kim; R M Rohan; K A Colby; K T Yeo; A P Adamis
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

Review 7.  Integrins and GTPases in tumour cell growth, motility and invasion.

Authors:  P Keely; L Parise; R Juliano
Journal:  Trends Cell Biol       Date:  1998-03       Impact factor: 20.808

8.  The CD40-induced signaling pathway in endothelial cells resulting in the overexpression of vascular endothelial growth factor involves Ras and phosphatidylinositol 3-kinase.

Authors:  Jesse A Flaxenburg; Michael Melter; Peter H Lapchak; David M Briscoe; Soumitro Pal
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

9.  Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2.

Authors:  W Roeckl; D Hecht; H Sztajer; J Waltenberger; A Yayon; H A Weich
Journal:  Exp Cell Res       Date:  1998-05-25       Impact factor: 3.905

10.  Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors.

Authors:  Sunyoung Lee; Shahla M Jilani; Ganka V Nikolova; Darren Carpizo; M Luisa Iruela-Arispe
Journal:  J Cell Biol       Date:  2005-05-23       Impact factor: 10.539

View more
  25 in total

1.  Rap1 GTPase Inhibits Tumor Necrosis Factor-α-Induced Choroidal Endothelial Migration via NADPH Oxidase- and NF-κB-Dependent Activation of Rac1.

Authors:  Haibo Wang; Lori Fotheringham; Erika S Wittchen; M Elizabeth Hartnett
Journal:  Am J Pathol       Date:  2015-10-23       Impact factor: 4.307

2.  The small GTPase Rap1 is a novel regulator of RPE cell barrier function.

Authors:  Erika S Wittchen; M Elizabeth Hartnett
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-27       Impact factor: 4.799

3.  Breaking barriers: insight into the pathogenesis of neovascular age-related macular degeneration.

Authors:  Haibo Wang; Erika S Wittchen; M Elizabeth Hartnett
Journal:  Eye Brain       Date:  2011-09-27

4.  Upregulation of CCR3 by age-related stresses promotes choroidal endothelial cell migration via VEGF-dependent and -independent signaling.

Authors:  Haibo Wang; Erika S Wittchen; Yanchao Jiang; Balamurali Ambati; Hans E Grossniklaus; M Elizabeth Hartnett
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-21       Impact factor: 4.799

Review 5.  Aerobic Glycolysis Hypothesis Through WNT/Beta-Catenin Pathway in Exudative Age-Related Macular Degeneration.

Authors:  Alexandre Vallée; Yves Lecarpentier; Rémy Guillevin; Jean-Noël Vallée
Journal:  J Mol Neurosci       Date:  2017-07-08       Impact factor: 3.444

6.  Activation of Rap1 inhibits NADPH oxidase-dependent ROS generation in retinal pigment epithelium and reduces choroidal neovascularization.

Authors:  Haibo Wang; Yanchao Jiang; Dallas Shi; Lawrence A Quilliam; Magdalena Chrzanowska-Wodnicka; Erika S Wittchen; Dean Y Li; M Elizabeth Hartnett
Journal:  FASEB J       Date:  2013-09-16       Impact factor: 5.191

7.  Attenuation of choroidal neovascularization by β(2)-adrenoreceptor antagonism.

Authors:  Jeremy A Lavine; Yanzhi Sang; Shoujian Wang; Michael S Ip; Nader Sheibani
Journal:  JAMA Ophthalmol       Date:  2013-03       Impact factor: 7.389

8.  IQGAP1 causes choroidal neovascularization by sustaining VEGFR2-mediated Rac1 activation.

Authors:  Haibo Wang; Aniket Ramshekar; Eric Kunz; David B Sacks; M Elizabeth Hartnett
Journal:  Angiogenesis       Date:  2020-08-11       Impact factor: 9.596

9.  3D iPSC modeling of the retinal pigment epithelium-choriocapillaris complex identifies factors involved in the pathology of macular degeneration.

Authors:  Kannan V Manian; Chad A Galloway; Sonal Dalvi; Anthony A Emanuel; Jared A Mereness; Whitney Black; Lauren Winschel; Celia Soto; Yiming Li; Yuanhui Song; William DeMaria; Akhilesh Kumar; Igor Slukvin; Michael P Schwartz; William L Murphy; Bela Anand-Apte; Mina Chung; Danielle S W Benoit; Ruchira Singh
Journal:  Cell Stem Cell       Date:  2021-03-29       Impact factor: 24.633

Review 10.  Oxidative and Nitrosative Stress in Age-Related Macular Degeneration: A Review of Their Role in Different Stages of Disease.

Authors:  Caterina Toma; Stefano De Cillà; Aurelio Palumbo; Divya Praveen Garhwal; Elena Grossini
Journal:  Antioxidants (Basel)       Date:  2021-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.